Pulmonary disease treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/56 (2006.01) A61K 9/72 (2006.01) A61P 11/06 (2006.01) A61P 11/08 (2006.01)

Patent

CA 2540005

The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 ~g of the inhaled particles have sizes equal to or less than 6.5 ~m.

L'invention concerne le traitement d'une maladie pulmonaire chronique obstructive, consistant à administrer par inhalation des particules de furoate de mométasone en doses journalières, dont environ 250 ?g des particules inhalées possèdent des dimensions équivalentes ou inférieures à 6.5 ?m.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pulmonary disease treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pulmonary disease treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary disease treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1603943

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.